These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 16989069)

  • 1. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia and progressive renal disease.
    Keane WF; Mulcahy WS; Kasiske BL; Kim Y; O'Donnell MP
    Kidney Int Suppl; 1991 Apr; 31():S41-8. PubMed ID: 2046270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipids on glomerular injury and progression of renal disease.
    Keane WF
    Verh K Acad Geneeskd Belg; 1994; 56(2):91-104. PubMed ID: 8048270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids.
    van Goor H; Fidler V; Weening JJ; Grond J
    Lab Invest; 1991 Jun; 64(6):754-65. PubMed ID: 2046327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids and progressive renal failure.
    Keane WF
    Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and renal disease.
    Trevisan R; Dodesini AR; Lepore G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
    Shohat J; Boner G
    Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid abnormalities in kidney diseases--significance of radical hypolipemic therapy (LDL-apheresis)].
    Bartuś S; Kuźniewski M; Chmiel G; Dembińska-Kieć A; Sułowicz W
    Przegl Lek; 1999; 56(5):377-80. PubMed ID: 10554576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular structures and lipids in progressive renal disease.
    Moorhead JF; Wheeler DC; Varghese Z
    Am J Med; 1989 Nov; 87(5N):12N-20N. PubMed ID: 2486539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonimmunologic mechanisms of glomerular injury.
    Olson JL; Heptinstall RH
    Lab Invest; 1988 Nov; 59(5):564-78. PubMed ID: 3054312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic differences in susceptibility to glomerular sclerosis: a role for lipids?
    Grond J; Muller EW; Weening JJ
    Am J Med; 1989 Nov; 87(5N):30N-33N. PubMed ID: 2486543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
    Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy.
    Avram MM
    Am J Med; 1989 Nov; 87(5N):39N-41N. PubMed ID: 2486545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation.
    van Goor H; van der Horst ML; Fidler V; Grond J
    Lab Invest; 1992 May; 66(5):564-71. PubMed ID: 1573851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia and glomerular sclerosis: an alternative viewpoint.
    Anderson S; King AJ; Brenner BM
    Am J Med; 1989 Nov; 87(5N):34N-38N. PubMed ID: 2486544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of altered lipid metabolism in the progression of renal disease: experimental evidence.
    Keane WF; Kasiske BL; O'Donnell MP; Kim Y
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):38-42. PubMed ID: 2024671
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of progression of renal disease: growth factors and related mechanisms.
    Benigni A; Remuzzi G
    J Hypertens Suppl; 1998 Sep; 16(4):S9-12. PubMed ID: 9817186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of high-lipid diet on glomerular mesangial matrix in adriamycin-induced nephrotic rats].
    Song H; Li X; Wei M; Zhu C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Oct; 22(5):471-5. PubMed ID: 12903432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.